Transforming ALS Diagnosis and Drug Discovery
Breakthrough diagnosis and treatments
—reimagining ALS care with cutting-edge technology.
About SONoALS
Mission-Driven Science
SONoALS, Inc. is a pioneering startup to redefine how ALS is diagnosed and treated. Our mission is to bring non-invasive, data-rich monitoring to the frontlines of neurodegenerative disease research. The team unites clinical neuroscience and biomedical engineering to make that mission a reality.
Breakthrough Technology
Wearable Ultrasound × AI-Powered Analysis
Revolutionary ultrasound technology combined with AI-powered analysis for Amyotrophic Lateral Sclerosis (ALS) monitoring and diagnosis.
Precision Tools for ALS Research and Beyond
Transforming healthcare through innovative applications in early diagnosis and drug discovery.
Applications
Early and Non-invasive Diagnosis of ALS
Drug Discovery Integration:
- Rapid and objective monitoring of treatment response
- Shortening drug trial durations
- Enabling patient stratification for Clinical Trials
- Supporting in-patient experimental drug screening
News & Press
Latest updates and achievements from SONoALS
Patent filed: Diagnostic and therapy technology using ultrasound
Nov 17, 2025
Domestic patent application filed (JP 2025-196949)
Selected for MEDISO Accompanied Support Program (MHLW)
Nov 6, 2025
Selected for the MEDISO accompanied support program by Japan's Ministry of Health, Labour and Welfare
Selected for Program to Promote Practical Implementation of Innovations for Neurological Disorders (JNS)
Sep 22, 2025
Project: "ALS diagnostic support and drug efficacy evaluation system using a wearable ultrasound device and fasciculation analysis AI"
Get in Touch
Ready to learn more about our revolutionary ALS technology? Let's connect.
Company Information
Address
WALLSQUARE Kitanozaka
2-13-15 Yamamoto Ave., Chuo Ward
Kobe City, Hyogo 650-0003, Japan
chizu@sonoals.com
Established
May 2025
Tadashi Kojima
SONoALS